论文部分内容阅读
目的研讨新生儿黄疸合用间断蓝光、茵栀黄口服液及宝乐安(酪酸梭菌活菌散)治疗的临床价值。方法随机从我院2014年8月-2016年8月选取156例新生儿黄疸做试验与研究,每组78例,Ⅰ组患儿单纯接受蓝光照射,Ⅱ组患儿在上述处理下接受茵栀黄口服液与宝乐安用药,对该两种方案的临床应用情况做评估。结果Ⅱ组患儿在接受治疗后取得了97.4%的总治愈率,显著比Ⅰ组的总治愈率(87.2%)提高,统计学成立(P<0.05)。两组治疗前后的胆红素检测结果相差不大,统计学不成立(P>0.05),但在消退时间上,Ⅱ组有显著缩短,优于Ⅰ组,统计学成立(P<0.05)。结论对新生儿黄疸应用间断蓝光配合茵栀黄口服液、宝乐安治疗,疗效显著,对促进黄疸消退更有利,值得推荐。
Objective To study the clinical value of combined neonatal jaundice with intermittent blue light, Yinzhihuang oral liquid and Baole’an (Clostridium butyricum). Methods A total of 156 cases of neonatal jaundice were randomly selected from our hospital from August 2014 to August 2016, 78 cases in each group. The children in group Ⅰ received blue light irradiation only. The children in group Ⅱ accepted Yinzhi Yellow oral solution and Bao Luan medication, to evaluate the clinical application of the two programs. Results The total cure rate of group Ⅱ was 97.4% after treatment, which was significantly higher than that of group Ⅰ (87.2%). The statistics was established (P <0.05). The results of bilirubin before and after treatment showed no significant difference between the two groups (P> 0.05). However, in the subsided time, group Ⅱ was significantly shorter than group Ⅰ (P <0.05). Conclusion Neonatal jaundice with intermittent blue light with Yinzhihuang oral solution, Bao Luan treatment, significant effect, to promote jaundice more favorable, it is recommended.